Assembled from the company's filings and exchange data as of today. Download PDF renders this page on the server; the narrative sections arrive with the Nexa composer.
Dossier · iSERA LIFESCIENCES LIMITED · 29 October 2026Page 1 of 3
Company Dossier
MarketPing Research · factual · no rating expressed
iSERA LIFESCIENCES LIMITED
BSE: 534920
BSE: 534920
Information Technology › Information Technology › IT - Software › Computers - Software & Consulting
iSERA LIFESCIENCES LIMITED
StateQ4 FY20 filed
Last close · 28 Oct 2026₹143.90
Market cap₹0.1k cr
TTM P/E · P/B · EV/EBITDA— · 1106.92 · —
iSERA LIFESCIENCES LIMITED is a IT - Software company. The annual-report business brief for this company has not been generated yet; the numbers below are as filed.
What a broker report prints here — the analyst's thesis. This dossier prints the filed record instead; the narrative read of the latest results, the guidance ledger and the earnings-call summary are the composer's sections (INSTITUTIONAL-PLAN.md M3) and are not yet produced.
Exhibit 1: Financial summary, FY19–FY20 (all audited; no estimate years)
| ₹ crore · consolidated | FY19 | FY20 |
|---|---|---|
| Revenue | 26 | 2 |
| EBITDA (ex other income) | 0 | (0) |
| margin % | 1.9 | (2.5) |
| Owners' profit | (0) | 0 |
| EPS, as reported (₹) | (0.04) | (42.14) |
| ROE % · ROCE % | (8.8) · 4.2 | (371.4) · (2.6) |
| Debt / equity (x) | 21.62 | 58.39 |
| Cash from operations | — | — |
| Capex | — | — |
Source: SEBI results XBRL as filed with BSE/NSE; EBITDA excludes other income.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · iSERA LIFESCIENCES LIMITED · 29 October 2026Page 2 of 3
Exhibit 2: Quarterly performance, last 3 quarters
| ₹ crore | Q4 FY19 | Q1 FY20 | Q4 FY20 |
|---|---|---|---|
| Revenue | 4 | 1 | 0 |
| Profit before tax | (0) | (0) | (0) |
| Net profit | (0) | (0) | (0) |
| EPS (₹) | (0.03) | (0.12) | (19.60) |
Source: quarterly results as filed; the balance sheet is filed half-yearly and is not repeated here.
Exhibit 3: Peers — basic industry group, by market cap
| Company | M.cap ₹ cr | P/E | P/B | EV/EBITDA | ROE % | ROCE % | Rev CAGR 5y % | EBITDA m. % |
|---|---|---|---|---|---|---|---|---|
| TATA CONSULTANCY SERV LT | 8,87,298 | 17.8 | 8.18 | 12.2 | 45.6 | 53.9 | 10.2 | 26.9 |
| INFOSYS LIMITED | 4,55,550 | 15.2 | 4.88 | 9.6 | 31.6 | 38.6 | 12.2 | 25.7 |
| HCL TECHNOLOGIES LTD | 3,78,281 | 21.6 | 5.03 | 13.6 | 22.1 | 26.2 | 11.5 | 20.9 |
| WIPRO LTD | 1,82,720 | 14.6 | 2.07 | 8.7 | 15.0 | 17.1 | 8.4 | 22.9 |
| TECH MAHINDRA LIMITED | 1,74,293 | 30.7 | 5.79 | 19.5 | 16.0 | 18.8 | 8.5 | 16.8 |
| LTM LIMITED | 1,21,357 | 23.2 | 5.03 | 14.7 | 20.7 | 24.8 | 27.9 | 20.0 |
| PERSISTENT SYSTEMS LTD | 91,811 | 47.3 | 11.71 | 31.4 | 23.8 | 28.5 | 28.6 | 17.8 |
| COFORGE LIMITED | 86,606 | 39.8 | 8.95 | 30.9 | 18.0 | 17.2 | 28.6 | 18.6 |
Source: exchange data and filed statements via the screener; multiples at current prices.
Exhibit 4: Where the company sits in its group
| Metric | Company | Group median | Rank | Better than |
|---|---|---|---|---|
| P/B | 1076.6 | 2.6 | 65 of 65 | 0% |
| ROCE | (6.0) | 14.2 | 69 of 76 | 9% |
| ROE | (371.4) | 11.5 | 63 of 64 | 2% |
| Debt / Equity | 58.4 | 0.0 | 65 of 65 | 0% |
| EBITDA margin | 166.7 | 18.4 | 1 of 65 | 100% |
| Market cap | 121 | 419 | 52 of 76 | 32% |
Source: MarketPing peer ranks; a rank is a measurement, not a view.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in
Dossier · iSERA LIFESCIENCES LIMITED · 29 October 2026Page 3 of 3
Exhibit 5: Filings of the last 90 days, with the measured price reaction
| Date · filing | Category | Importance | Next day % | 5-day % |
|---|---|---|---|---|
| 13 Oct 2026 · RTA compliance certificate under SEBI Reg 74(5) for Q2 FY27 | compliance | minimal | — | — |
| 8 Oct 2026 · Promoter group acquires shares via preferential allotment on share swap basis | fund raising | medium | — | — |
| 7 Oct 2026 · Promoter Archana Lonkar acquires shares via share swap | ownership changes | medium | — | — |
| 7 Oct 2026 · Promoter gets shares via preferential swap, stake dilutes to 6.39% | ownership changes | high | — | — |
| 6 Oct 2026 · Promoter Dhairyasheel Yadav gets 4.5 lakh shares via share swap allotment | ownership changes | high | — | — |
| 6 Oct 2026 · Promoter Sumeet Dhanraj Garad acquires 4.06% stake via share swap | ownership changes | high | — | — |
| 6 Oct 2026 · Promoter group gets 86.13 lakh shares via share swap; stake now 55.07% | ownership changes | high | — | — |
| 1 Oct 2026 · Board okays share swap allotment of 1.61 crore shares at Rs 48.20 | fund raising | high | — | — |
| 1 Oct 2026 · Allotment of 1.61 crore shares via share swap to acquire iSERA Biological Limited | fund raising | high | — | — |
| 30 Sept 2026 · iSERA Lifesciences 34th AGM: Both resolutions passed with 100 percent approval | compliance | minimal | — | — |
Source: exchange announcements; each reaction is measured from the close before the filing. Next day = the close one session after the reaction day (the first session that could trade the filing).
How to read this document
| Where a broker report shows | This document shows | Why |
|---|---|---|
| A rating (BUY / ADD / REDUCE / SELL) | A state: the latest filed quarter and the measured reactions | an event is a fact; a rating is an opinion that requires SEBI RA registration |
| A target price and upside | The current price and the multiples against the group | a target is a forecast; a multiple is a measurement |
| Estimate years marked E | More audited years; no estimates | MarketPing publishes no forecasts — your own model lives on the Models page |
Sources, method and disclosures
This document is a statistical summary of publicly filed information and market data, prepared by software from primary sources: SEBI results XBRL filed with BSE and NSE, LODR disclosures, shareholding patterns, exchange price data. It contains no research recommendation, no price target and no opinion on the merits of any security, and is not a research report within the meaning of the SEBI (Research Analysts) Regulations, 2014, Regulation 2(1)(w)(vii). Financial statements are as filed (consolidated where the company files consolidated results). Ratios are computed over filed lines. Where a figure is unavailable the table shows a dash rather than an estimate. The business brief is written by MarketPing's reader from the annual report and checked against it; no figure in a table was generated by a model. Nothing here constitutes investment advice, an offer or a solicitation; readers should consult a SEBI-registered adviser before acting. MarketPing is not a SEBI-registered intermediary.
Every figure is a filed number or a ratio over filed numbers · No rating, target or fair value is expressed · Disclosures on the last pagemarketping.in